0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Chronic Gout Treatment Drug Market Research Report 2023
Published Date: November 2023
|
Report Code: QYRE-Auto-24Y15383
Home | Market Reports | Health| Health Conditions| Arthritis
Global Chronic Gout Treatment Drug Market Research Report 2023
BUY CHAPTERS

Global Chronic Gout Treatment Drug Market Research Report 2023

Code: QYRE-Auto-24Y15383
Report
November 2023
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Chronic Gout Treatment Drug Market Size

According to new survey, global Chronic Gout Treatment Drug market is projected to reach US$ 1635.6 million in 2029, increasing from US$ 1203 million in 2022, with the CAGR of 4.5% during the period of 2023 to 2029.

Chronic Gout Treatment Drug Market

Chronic Gout Treatment Drug Market

Chronic gout is a metabolic disease often associated with high uric acid levels and the deposition of uric acid crystals. The main goals of chronic gout treatment medications are to reduce the symptoms of gout attacks, lower uric acid levels, and prevent the formation of uric acid crystals. As medicine advances, more and more research is focusing on personalized treatment, selecting the best treatment method based on the patient's genetic and physiological characteristics. Developments in pharmaceutical technology have made drug delivery more convenient and consistent, thereby improving treatment compliance.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Chronic Gout Treatment Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Chronic Gout Treatment Drug Market Report

Report Metric Details
Report Name Chronic Gout Treatment Drug Market
Accounted market size in 2022 US$ 1203 million
Forecasted market size in 2029 US$ 1635.6 million
CAGR 4.5%
Base Year 2022
Forecasted years 2023 - 2029
Segment by Type
  • Pill
  • Capsule
  • Others
Segment by Application
  • General Hospital
  • Specialty Hospital
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GE Healthcare, AstraZeneca, Pfizer, Merck, Novartis, Takeda Pharmaceuticals, Sanofi, Boston Biomedical, Tianjin Kingyork Group, Atom Bioscience and Pharmaceutical, Wuhan Humanwell Pharmaceutical Group, Fosun Pharma, Chongqing Taiji Industry
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

How fast is Chronic Gout Treatment Drug Market growing?

Ans: The Chronic Gout Treatment Drug Market witnessing a CAGR of 4.5% during the forecast period 2023-2029.

What is the Chronic Gout Treatment Drug Market size in 2029?

Ans: The Chronic Gout Treatment Drug Market size in 2029 will be US$ 1635.6 million.

Who are the main players in the Chronic Gout Treatment Drug Market report?

Ans: The main players in the Chronic Gout Treatment Drug Market are GE Healthcare, AstraZeneca, Pfizer, Merck, Novartis, Takeda Pharmaceuticals, Sanofi, Boston Biomedical, Tianjin Kingyork Group, Atom Bioscience and Pharmaceutical, Wuhan Humanwell Pharmaceutical Group, Fosun Pharma, Chongqing Taiji Industry

What are the Application segmentation covered in the Chronic Gout Treatment Drug Market report?

Ans: The Applications covered in the Chronic Gout Treatment Drug Market report are General Hospital, Specialty Hospital, Others

What are the Type segmentation covered in the Chronic Gout Treatment Drug Market report?

Ans: The Types covered in the Chronic Gout Treatment Drug Market report are Pill, Capsule, Others

1 Chronic Gout Treatment Drug Market Overview
1.1 Product Overview and Scope of Chronic Gout Treatment Drug
1.2 Chronic Gout Treatment Drug Segment by Type
1.2.1 Global Chronic Gout Treatment Drug Market Value Comparison by Type (2023-2029)
1.2.2 Pill
1.2.3 Capsule
1.2.4 Others
1.3 Chronic Gout Treatment Drug Segment by Application
1.3.1 Global Chronic Gout Treatment Drug Market Value by Application: (2023-2029)
1.3.2 General Hospital
1.3.3 Specialty Hospital
1.3.4 Others
1.4 Global Chronic Gout Treatment Drug Market Size Estimates and Forecasts
1.4.1 Global Chronic Gout Treatment Drug Revenue 2018-2029
1.4.2 Global Chronic Gout Treatment Drug Sales 2018-2029
1.4.3 Global Chronic Gout Treatment Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Chronic Gout Treatment Drug Market Competition by Manufacturers
2.1 Global Chronic Gout Treatment Drug Sales Market Share by Manufacturers (2018-2023)
2.2 Global Chronic Gout Treatment Drug Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Chronic Gout Treatment Drug Average Price by Manufacturers (2018-2023)
2.4 Global Chronic Gout Treatment Drug Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Chronic Gout Treatment Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Chronic Gout Treatment Drug, Product Type & Application
2.7 Chronic Gout Treatment Drug Market Competitive Situation and Trends
2.7.1 Chronic Gout Treatment Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Chronic Gout Treatment Drug Players Market Share by Revenue
2.7.3 Global Chronic Gout Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chronic Gout Treatment Drug Retrospective Market Scenario by Region
3.1 Global Chronic Gout Treatment Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Chronic Gout Treatment Drug Global Chronic Gout Treatment Drug Sales by Region: 2018-2029
3.2.1 Global Chronic Gout Treatment Drug Sales by Region: 2018-2023
3.2.2 Global Chronic Gout Treatment Drug Sales by Region: 2024-2029
3.3 Global Chronic Gout Treatment Drug Global Chronic Gout Treatment Drug Revenue by Region: 2018-2029
3.3.1 Global Chronic Gout Treatment Drug Revenue by Region: 2018-2023
3.3.2 Global Chronic Gout Treatment Drug Revenue by Region: 2024-2029
3.4 North America Chronic Gout Treatment Drug Market Facts & Figures by Country
3.4.1 North America Chronic Gout Treatment Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Chronic Gout Treatment Drug Sales by Country (2018-2029)
3.4.3 North America Chronic Gout Treatment Drug Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Chronic Gout Treatment Drug Market Facts & Figures by Country
3.5.1 Europe Chronic Gout Treatment Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Chronic Gout Treatment Drug Sales by Country (2018-2029)
3.5.3 Europe Chronic Gout Treatment Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Chronic Gout Treatment Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Chronic Gout Treatment Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Chronic Gout Treatment Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Chronic Gout Treatment Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Chronic Gout Treatment Drug Market Facts & Figures by Country
3.7.1 Latin America Chronic Gout Treatment Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Chronic Gout Treatment Drug Sales by Country (2018-2029)
3.7.3 Latin America Chronic Gout Treatment Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Chronic Gout Treatment Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Chronic Gout Treatment Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Chronic Gout Treatment Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Chronic Gout Treatment Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Chronic Gout Treatment Drug Sales by Type (2018-2029)
4.1.1 Global Chronic Gout Treatment Drug Sales by Type (2018-2023)
4.1.2 Global Chronic Gout Treatment Drug Sales by Type (2024-2029)
4.1.3 Global Chronic Gout Treatment Drug Sales Market Share by Type (2018-2029)
4.2 Global Chronic Gout Treatment Drug Revenue by Type (2018-2029)
4.2.1 Global Chronic Gout Treatment Drug Revenue by Type (2018-2023)
4.2.2 Global Chronic Gout Treatment Drug Revenue by Type (2024-2029)
4.2.3 Global Chronic Gout Treatment Drug Revenue Market Share by Type (2018-2029)
4.3 Global Chronic Gout Treatment Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global Chronic Gout Treatment Drug Sales by Application (2018-2029)
5.1.1 Global Chronic Gout Treatment Drug Sales by Application (2018-2023)
5.1.2 Global Chronic Gout Treatment Drug Sales by Application (2024-2029)
5.1.3 Global Chronic Gout Treatment Drug Sales Market Share by Application (2018-2029)
5.2 Global Chronic Gout Treatment Drug Revenue by Application (2018-2029)
5.2.1 Global Chronic Gout Treatment Drug Revenue by Application (2018-2023)
5.2.2 Global Chronic Gout Treatment Drug Revenue by Application (2024-2029)
5.2.3 Global Chronic Gout Treatment Drug Revenue Market Share by Application (2018-2029)
5.3 Global Chronic Gout Treatment Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Corporation Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GE Healthcare Chronic Gout Treatment Drug Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AstraZeneca Chronic Gout Treatment Drug Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer Chronic Gout Treatment Drug Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck Chronic Gout Treatment Drug Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Novartis Chronic Gout Treatment Drug Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Takeda Pharmaceuticals
6.6.1 Takeda Pharmaceuticals Corporation Information
6.6.2 Takeda Pharmaceuticals Description and Business Overview
6.6.3 Takeda Pharmaceuticals Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Takeda Pharmaceuticals Chronic Gout Treatment Drug Product Portfolio
6.6.5 Takeda Pharmaceuticals Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sanofi Chronic Gout Treatment Drug Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Boston Biomedical
6.8.1 Boston Biomedical Corporation Information
6.8.2 Boston Biomedical Description and Business Overview
6.8.3 Boston Biomedical Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Boston Biomedical Chronic Gout Treatment Drug Product Portfolio
6.8.5 Boston Biomedical Recent Developments/Updates
6.9 Tianjin Kingyork Group
6.9.1 Tianjin Kingyork Group Corporation Information
6.9.2 Tianjin Kingyork Group Description and Business Overview
6.9.3 Tianjin Kingyork Group Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Tianjin Kingyork Group Chronic Gout Treatment Drug Product Portfolio
6.9.5 Tianjin Kingyork Group Recent Developments/Updates
6.10 Atom Bioscience and Pharmaceutical
6.10.1 Atom Bioscience and Pharmaceutical Corporation Information
6.10.2 Atom Bioscience and Pharmaceutical Description and Business Overview
6.10.3 Atom Bioscience and Pharmaceutical Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Atom Bioscience and Pharmaceutical Chronic Gout Treatment Drug Product Portfolio
6.10.5 Atom Bioscience and Pharmaceutical Recent Developments/Updates
6.11 Wuhan Humanwell Pharmaceutical Group
6.11.1 Wuhan Humanwell Pharmaceutical Group Corporation Information
6.11.2 Wuhan Humanwell Pharmaceutical Group Chronic Gout Treatment Drug Description and Business Overview
6.11.3 Wuhan Humanwell Pharmaceutical Group Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Wuhan Humanwell Pharmaceutical Group Chronic Gout Treatment Drug Product Portfolio
6.11.5 Wuhan Humanwell Pharmaceutical Group Recent Developments/Updates
6.12 Fosun Pharma
6.12.1 Fosun Pharma Corporation Information
6.12.2 Fosun Pharma Chronic Gout Treatment Drug Description and Business Overview
6.12.3 Fosun Pharma Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Fosun Pharma Chronic Gout Treatment Drug Product Portfolio
6.12.5 Fosun Pharma Recent Developments/Updates
6.13 Chongqing Taiji Industry
6.13.1 Chongqing Taiji Industry Corporation Information
6.13.2 Chongqing Taiji Industry Chronic Gout Treatment Drug Description and Business Overview
6.13.3 Chongqing Taiji Industry Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Chongqing Taiji Industry Chronic Gout Treatment Drug Product Portfolio
6.13.5 Chongqing Taiji Industry Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chronic Gout Treatment Drug Industry Chain Analysis
7.2 Chronic Gout Treatment Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chronic Gout Treatment Drug Production Mode & Process
7.4 Chronic Gout Treatment Drug Sales and Marketing
7.4.1 Chronic Gout Treatment Drug Sales Channels
7.4.2 Chronic Gout Treatment Drug Distributors
7.5 Chronic Gout Treatment Drug Customers
8 Chronic Gout Treatment Drug Market Dynamics
8.1 Chronic Gout Treatment Drug Industry Trends
8.2 Chronic Gout Treatment Drug Market Drivers
8.3 Chronic Gout Treatment Drug Market Challenges
8.4 Chronic Gout Treatment Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Chronic Gout Treatment Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Chronic Gout Treatment Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Chronic Gout Treatment Drug Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Chronic Gout Treatment Drug Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global Chronic Gout Treatment Drug Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Chronic Gout Treatment Drug Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Chronic Gout Treatment Drug Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Chronic Gout Treatment Drug Average Price (US$/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Chronic Gout Treatment Drug, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Chronic Gout Treatment Drug, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Chronic Gout Treatment Drug, Product Type & Application
    Table 12. Global Key Manufacturers of Chronic Gout Treatment Drug, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Chronic Gout Treatment Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Gout Treatment Drug as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Chronic Gout Treatment Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Chronic Gout Treatment Drug Sales by Region (2018-2023) & (K Units)
    Table 18. Global Chronic Gout Treatment Drug Sales Market Share by Region (2018-2023)
    Table 19. Global Chronic Gout Treatment Drug Sales by Region (2024-2029) & (K Units)
    Table 20. Global Chronic Gout Treatment Drug Sales Market Share by Region (2024-2029)
    Table 21. Global Chronic Gout Treatment Drug Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Chronic Gout Treatment Drug Revenue Market Share by Region (2018-2023)
    Table 23. Global Chronic Gout Treatment Drug Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Chronic Gout Treatment Drug Revenue Market Share by Region (2024-2029)
    Table 25. North America Chronic Gout Treatment Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Chronic Gout Treatment Drug Sales by Country (2018-2023) & (K Units)
    Table 27. North America Chronic Gout Treatment Drug Sales by Country (2024-2029) & (K Units)
    Table 28. North America Chronic Gout Treatment Drug Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Chronic Gout Treatment Drug Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Chronic Gout Treatment Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Chronic Gout Treatment Drug Sales by Country (2018-2023) & (K Units)
    Table 32. Europe Chronic Gout Treatment Drug Sales by Country (2024-2029) & (K Units)
    Table 33. Europe Chronic Gout Treatment Drug Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Chronic Gout Treatment Drug Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Chronic Gout Treatment Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Chronic Gout Treatment Drug Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific Chronic Gout Treatment Drug Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific Chronic Gout Treatment Drug Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Chronic Gout Treatment Drug Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Chronic Gout Treatment Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Chronic Gout Treatment Drug Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America Chronic Gout Treatment Drug Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America Chronic Gout Treatment Drug Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Chronic Gout Treatment Drug Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Chronic Gout Treatment Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Chronic Gout Treatment Drug Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa Chronic Gout Treatment Drug Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa Chronic Gout Treatment Drug Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Chronic Gout Treatment Drug Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Chronic Gout Treatment Drug Sales (K Units) by Type (2018-2023)
    Table 51. Global Chronic Gout Treatment Drug Sales (K Units) by Type (2024-2029)
    Table 52. Global Chronic Gout Treatment Drug Sales Market Share by Type (2018-2023)
    Table 53. Global Chronic Gout Treatment Drug Sales Market Share by Type (2024-2029)
    Table 54. Global Chronic Gout Treatment Drug Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Chronic Gout Treatment Drug Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Chronic Gout Treatment Drug Revenue Market Share by Type (2018-2023)
    Table 57. Global Chronic Gout Treatment Drug Revenue Market Share by Type (2024-2029)
    Table 58. Global Chronic Gout Treatment Drug Price (US$/Unit) by Type (2018-2023)
    Table 59. Global Chronic Gout Treatment Drug Price (US$/Unit) by Type (2024-2029)
    Table 60. Global Chronic Gout Treatment Drug Sales (K Units) by Application (2018-2023)
    Table 61. Global Chronic Gout Treatment Drug Sales (K Units) by Application (2024-2029)
    Table 62. Global Chronic Gout Treatment Drug Sales Market Share by Application (2018-2023)
    Table 63. Global Chronic Gout Treatment Drug Sales Market Share by Application (2024-2029)
    Table 64. Global Chronic Gout Treatment Drug Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Chronic Gout Treatment Drug Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Chronic Gout Treatment Drug Revenue Market Share by Application (2018-2023)
    Table 67. Global Chronic Gout Treatment Drug Revenue Market Share by Application (2024-2029)
    Table 68. Global Chronic Gout Treatment Drug Price (US$/Unit) by Application (2018-2023)
    Table 69. Global Chronic Gout Treatment Drug Price (US$/Unit) by Application (2024-2029)
    Table 70. GE Healthcare Corporation Information
    Table 71. GE Healthcare Description and Business Overview
    Table 72. GE Healthcare Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 73. GE Healthcare Chronic Gout Treatment Drug Product
    Table 74. GE Healthcare Recent Developments/Updates
    Table 75. AstraZeneca Corporation Information
    Table 76. AstraZeneca Description and Business Overview
    Table 77. AstraZeneca Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 78. AstraZeneca Chronic Gout Treatment Drug Product
    Table 79. AstraZeneca Recent Developments/Updates
    Table 80. Pfizer Corporation Information
    Table 81. Pfizer Description and Business Overview
    Table 82. Pfizer Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 83. Pfizer Chronic Gout Treatment Drug Product
    Table 84. Pfizer Recent Developments/Updates
    Table 85. Merck Corporation Information
    Table 86. Merck Description and Business Overview
    Table 87. Merck Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 88. Merck Chronic Gout Treatment Drug Product
    Table 89. Merck Recent Developments/Updates
    Table 90. Novartis Corporation Information
    Table 91. Novartis Description and Business Overview
    Table 92. Novartis Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 93. Novartis Chronic Gout Treatment Drug Product
    Table 94. Novartis Recent Developments/Updates
    Table 95. Takeda Pharmaceuticals Corporation Information
    Table 96. Takeda Pharmaceuticals Description and Business Overview
    Table 97. Takeda Pharmaceuticals Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 98. Takeda Pharmaceuticals Chronic Gout Treatment Drug Product
    Table 99. Takeda Pharmaceuticals Recent Developments/Updates
    Table 100. Sanofi Corporation Information
    Table 101. Sanofi Description and Business Overview
    Table 102. Sanofi Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 103. Sanofi Chronic Gout Treatment Drug Product
    Table 104. Sanofi Recent Developments/Updates
    Table 105. Boston Biomedical Corporation Information
    Table 106. Boston Biomedical Description and Business Overview
    Table 107. Boston Biomedical Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 108. Boston Biomedical Chronic Gout Treatment Drug Product
    Table 109. Boston Biomedical Recent Developments/Updates
    Table 110. Tianjin Kingyork Group Corporation Information
    Table 111. Tianjin Kingyork Group Description and Business Overview
    Table 112. Tianjin Kingyork Group Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 113. Tianjin Kingyork Group Chronic Gout Treatment Drug Product
    Table 114. Tianjin Kingyork Group Recent Developments/Updates
    Table 115. Atom Bioscience and Pharmaceutical Corporation Information
    Table 116. Atom Bioscience and Pharmaceutical Description and Business Overview
    Table 117. Atom Bioscience and Pharmaceutical Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 118. Atom Bioscience and Pharmaceutical Chronic Gout Treatment Drug Product
    Table 119. Atom Bioscience and Pharmaceutical Recent Developments/Updates
    Table 120. Wuhan Humanwell Pharmaceutical Group Corporation Information
    Table 121. Wuhan Humanwell Pharmaceutical Group Description and Business Overview
    Table 122. Wuhan Humanwell Pharmaceutical Group Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 123. Wuhan Humanwell Pharmaceutical Group Chronic Gout Treatment Drug Product
    Table 124. Wuhan Humanwell Pharmaceutical Group Recent Developments/Updates
    Table 125. Fosun Pharma Corporation Information
    Table 126. Fosun Pharma Description and Business Overview
    Table 127. Fosun Pharma Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 128. Fosun Pharma Chronic Gout Treatment Drug Product
    Table 129. Fosun Pharma Recent Developments/Updates
    Table 130. Chongqing Taiji Industry Corporation Information
    Table 131. Chongqing Taiji Industry Description and Business Overview
    Table 132. Chongqing Taiji Industry Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 133. Chongqing Taiji Industry Chronic Gout Treatment Drug Product
    Table 134. Chongqing Taiji Industry Recent Developments/Updates
    Table 135. Key Raw Materials Lists
    Table 136. Raw Materials Key Suppliers Lists
    Table 137. Chronic Gout Treatment Drug Distributors List
    Table 138. Chronic Gout Treatment Drug Customers List
    Table 139. Chronic Gout Treatment Drug Market Trends
    Table 140. Chronic Gout Treatment Drug Market Drivers
    Table 141. Chronic Gout Treatment Drug Market Challenges
    Table 142. Chronic Gout Treatment Drug Market Restraints
    Table 143. Research Programs/Design for This Report
    Table 144. Key Data Information from Secondary Sources
    Table 145. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Chronic Gout Treatment Drug
    Figure 2. Global Chronic Gout Treatment Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Chronic Gout Treatment Drug Market Share by Type in 2022 & 2029
    Figure 4. Pill Product Picture
    Figure 5. Capsule Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Chronic Gout Treatment Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 8. Global Chronic Gout Treatment Drug Market Share by Application in 2022 & 2029
    Figure 9. General Hospital
    Figure 10. Specialty Hospital
    Figure 11. Others
    Figure 12. Global Chronic Gout Treatment Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Chronic Gout Treatment Drug Market Size (2018-2029) & (US$ Million)
    Figure 14. Global Chronic Gout Treatment Drug Sales (2018-2029) & (K Units)
    Figure 15. Global Chronic Gout Treatment Drug Average Price (US$/Unit) & (2018-2029)
    Figure 16. Chronic Gout Treatment Drug Report Years Considered
    Figure 17. Chronic Gout Treatment Drug Sales Share by Manufacturers in 2022
    Figure 18. Global Chronic Gout Treatment Drug Revenue Share by Manufacturers in 2022
    Figure 19. The Global 5 and 10 Largest Chronic Gout Treatment Drug Players: Market Share by Revenue in 2022
    Figure 20. Chronic Gout Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 21. Global Chronic Gout Treatment Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 22. North America Chronic Gout Treatment Drug Sales Market Share by Country (2018-2029)
    Figure 23. North America Chronic Gout Treatment Drug Revenue Market Share by Country (2018-2029)
    Figure 24. United States Chronic Gout Treatment Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 25. Canada Chronic Gout Treatment Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 26. Europe Chronic Gout Treatment Drug Sales Market Share by Country (2018-2029)
    Figure 27. Europe Chronic Gout Treatment Drug Revenue Market Share by Country (2018-2029)
    Figure 28. Germany Chronic Gout Treatment Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 29. France Chronic Gout Treatment Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. U.K. Chronic Gout Treatment Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. Italy Chronic Gout Treatment Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Russia Chronic Gout Treatment Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Asia Pacific Chronic Gout Treatment Drug Sales Market Share by Region (2018-2029)
    Figure 34. Asia Pacific Chronic Gout Treatment Drug Revenue Market Share by Region (2018-2029)
    Figure 35. China Chronic Gout Treatment Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. Japan Chronic Gout Treatment Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. South Korea Chronic Gout Treatment Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. India Chronic Gout Treatment Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. Australia Chronic Gout Treatment Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. China Taiwan Chronic Gout Treatment Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Southeast Asia Chronic Gout Treatment Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Latin America Chronic Gout Treatment Drug Sales Market Share by Country (2018-2029)
    Figure 43. Latin America Chronic Gout Treatment Drug Revenue Market Share by Country (2018-2029)
    Figure 44. Mexico Chronic Gout Treatment Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Brazil Chronic Gout Treatment Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Argentina Chronic Gout Treatment Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Colombia Chronic Gout Treatment Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Middle East & Africa Chronic Gout Treatment Drug Sales Market Share by Country (2018-2029)
    Figure 49. Middle East & Africa Chronic Gout Treatment Drug Revenue Market Share by Country (2018-2029)
    Figure 50. Turkey Chronic Gout Treatment Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Saudi Arabia Chronic Gout Treatment Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 52. UAE Chronic Gout Treatment Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 53. Global Sales Market Share of Chronic Gout Treatment Drug by Type (2018-2029)
    Figure 54. Global Revenue Market Share of Chronic Gout Treatment Drug by Type (2018-2029)
    Figure 55. Global Chronic Gout Treatment Drug Price (US$/Unit) by Type (2018-2029)
    Figure 56. Global Sales Market Share of Chronic Gout Treatment Drug by Application (2018-2029)
    Figure 57. Global Revenue Market Share of Chronic Gout Treatment Drug by Application (2018-2029)
    Figure 58. Global Chronic Gout Treatment Drug Price (US$/Unit) by Application (2018-2029)
    Figure 59. Chronic Gout Treatment Drug Value Chain
    Figure 60. Chronic Gout Treatment Drug Production Process
    Figure 61. Channels of Distribution (Direct Vs Distribution)
    Figure 62. Distributors Profiles
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Rheumatoid Arthritis Testing Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-33E11182
Mon Feb 05 00:00:00 UTC 2024

Add to Cart

Global Rheumatology Drugs Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-29B5986
Mon Feb 05 00:00:00 UTC 2024

Add to Cart

Global Psoriatic Arthritis Therapeutics Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-9A6304
Fri Feb 02 00:00:00 UTC 2024

Add to Cart

Global Rheumatic Disorders Drug Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-34K5776
Wed Jan 31 00:00:00 UTC 2024

Add to Cart